Details for New Drug Application (NDA): 089193
✉ Email this page to a colleague
NDA 089193 describes METHOCARBAMOL AND ASPIRIN, which is a drug marketed by Ivax Sub Teva Pharms, Mcneil, Par Pharm, and Stevens J, and is included in four NDAs. It is available from one supplier. Additional details are available on the METHOCARBAMOL AND ASPIRIN profile page.
The generic ingredient in METHOCARBAMOL AND ASPIRIN is aspirin; methocarbamol. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; methocarbamol profile page.
The generic ingredient in METHOCARBAMOL AND ASPIRIN is aspirin; methocarbamol. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Summary for 089193
| Tradename: | METHOCARBAMOL AND ASPIRIN |
| Applicant: | Mcneil |
| Ingredient: | aspirin; methocarbamol |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 325MG;400MG | ||||
| Approval Date: | Feb 12, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
